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Abstract
Implants like meshes for the reinforcement of tissues implement the formation of a
persistent inflammation with an ambient fibrotic reaction. In the inflammatory infil-
trate several distinct cell types have been identified, but CD68+ macrophages are
supposed to be most important. To investigate the collaboration among the various
cell types within the infiltrate we performed at explanted meshes from humans dou-
ble fluorescence staining with CD68 as a constant marker and a variety of other anti-
bodies as the second marker. The list of second markers includes lymphocytes (CD3,
CD4, CD8, CD16, CD56, FoxP3, and CD11b) stem cells (CD34), leucocytes (CD45,
CD15), macrophages (CD86, CD105, CD163, and CD206); deposition of EC matrix
(collagen-I, collagen-III, MMP2, and MMP8); Ki67 as a marker for proliferation; and
the tyrosine-protein kinase receptor AXL. The present study demonstrates within the
inflammatory infiltrate the abundant capability of CD68+ cells to co-express a huge
variety of other markers, including those of lymphocytes, varying between 5 and
83% of investigated cells. The observation of co-staining was not restricted to a spe-
cific polymer but was seen with polypropylene fibers as well as with fibers made of
polyvinylidene fluoride, although with differences in co-expression rates. The
persisting variability of these cells without the functional reduction toward differenti-
ated mature cell types may favor the lack of healing at the interface of meshes.
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1 | INTRODUCTION
Millions of patients are currently treated by mesh implants for the
treatment of hernias, pelvic floor weaknesses, vascular deficits, and
other disorders reinforcing tissues. However, integration of the deviceUwe Klinge and Axel Dievernich contributed equally to this study.
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within fat, muscle, or fibrous tissues is hampered by chronic inflamma-
tion with concomitant fibrotic scar formation. This state-of-affairs
favors a stiff-scar plate, nerve entrapments, chronic pain, migration, or
erosion of adjacent structures (Glazener et al., 2017). The long-term
safety of medical devices such as surgical meshes (Klosterhalfen &
Klinge, 2013; Nolfi et al., 2016) or breast implants (Bachour et al.,
2018) is decisively determined by the reaction of the host at the inter-
face, in most cases forming a foreign body granuloma (FBG), with
adjacent mononuclear inflammatory infiltrate and a surrounding
fibrotic capsule (Figure 1). For decades, macrophages have been con-
sidered as the dominant immune cell subset in this chronic inflamma-
tion, usually being identified by their morphology and surface
markers, such as CD68, CD86, or CD206 (Kunisch et al., 2004). Mac-
rophages display tissue-specific diversity and a plastic ability to
change their phenotype for production of cytokines to promote either
chronic inflammation or wound healing (Krzyszczyk, Schloss, Palmer, &
Berthiaume, 2018). These phenotypes are governed primarily by the
local tissue microenvironment (Davies & Taylor, 2015). To character-
ize the inflammatory infiltrate in more detail, in 2014 we had studied
the expression of various markers in the FBG of meshes by immuno-
histochemistry (Klinge, Dietz, Fet, & Klosterhalfen, 2014). The abun-
dant expression of CD68, CD45, as well as CD8 within the FBG,
suggested the possibility that macrophages alone may not be playing
the decisive part. Consistently, Tennyson et al. (2018) analyzed tissue
reactions to explanted pelvic floor meshes and confirmed the pres-
ence of abundant lymphocytes, for example, CD4+ helper T cells,
CD8+ cytotoxic T cells, or FOXP3+ regulatory T cells. Furthermore,
our observation of widespread positive staining of different markers
suggested that cells may co-express some of them.
Surface markers such as CD68, CD4, or CD8 are generally consid-
ered to reliably separate macrophages from lymphocytes. Although
flow cytometry experiments already have shown in some cell clusters
dual expression of CD68, and of CD4 or CD8 (Adamthwaite &
Cooley, 1994; Hameed, Hruban, Gage, Pettis, & Fox 3rd., 1994;
Kunisch et al., 2004; Murray et al., 2014; Wang, Windgassen, &
Papoutsakis, 2008; Zaynagetdinov et al., 2013), however, whether or
not such co-expression of macrophage and lymphocyte lineage
markers in the same cell are relevant in situ is unclear.
In the present study at explants from human patients, we tested in
the cells of the inflammatory infiltrate the expression of various cell
markers by double fluorescence staining to identify cell types other than
CD68+ and to look for possible co-expression in CD68+ cells. The list of
second markers include CD3 (lymphocytes), CD4 (T-helper), CD8 (cyto-
toxic T), CD16 (NK-cell), CD56 (NK-cell), FoxP3 (Treg), CD11b (DC),
CD34 (stem cell), CD45 (leucocytes), CD15 (granulocytes), macrophages
CD86 (pro-inflammatory M1), CD105 (activated, part of the TGF-
receptor complex), CD163 (part of the scavenger receptor complex),
CD206 (anti-inflammatory M2); deposition of EC matrix: collagen-I,
collagen-III, MMP2, MMP8; Ki67 served as marker for proliferation; and
AXL (tyrosine-protein kinase receptor) as inhibitor of the innate immune
response. Furthermore, we looked for the proliferative activity of CD68+
cells as indicative for a local self-renewal.
2 | MATERIALS AND METHODS
We analyzed 15 meshes made of polypropylene (PP), and five made of
polyvinylidene fluoride (PVDF), which all had been used for abdominal
wall hernia repair in humans, and were excised between 1999 and 2017
(approval by ethic committee EK 239/19). All the meshes of this study
are made of monofilaments, either of PP or PVDF. In some of the sam-
ples the material could be clearly identified: seven large pore Ultrapro®,
two Ventralex® with a layer of PTFE, two small pore plugs, one Vypro®,
one Proceed®, and five Dynamesh®-IPOM. In two others we cannot be
sure about the specific material used, other than a monofilament is used.
Human tissue samples of the spleen, liver, lymph node, and tonsil with-
out gross pathology served as healthy control tissue. All samples were
embedded in paraffin for subsequent investigations.
F IGURE 1 Foreign body reaction:
Foreign body giant cells, an inner
inflammatory infiltrate of
mononuclear cells with expression of
various markers (e.g. 25.7% CD68+),
and an outer fibrotic capsule with
collagen deposits around two fibers,
in contrast to collagen deposits in scar
tissue without this accumulation of
inflammatory cells
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Prior to immunofluorescence staining, mesh samples were checked
for the presence of mesh and FBGs by hematoxylin and eosin (supple-
mental Figure 1) as well as diaminobenzidine immunohistochemical
staining. All mesh samples showed the typical foreign body reaction
around the mesh fibers with an inner layer of inflammatory infiltrate,
followed by an outer fibrotic layer. Most specimens showed a varying
number of lymphocytes and foreign body giant cells (FBGCs), as well as
small vessels at the mesh–tissue interface. Eight of 15 mesh explants
made of PP were explanted due to hernia recurrence and three because
of low-grade infection, defined by an accumulation of at least 23 polymor-
phonuclear cells per high power field. The tissue reaction to PDVF
meshes was quite similar to PP meshes but less pronounced. The granu-
lomas were smaller in PDVF compared to PP, particularly their fibrotic tis-
sue layer; and the inflammatory infiltrate consists of smaller numbers of
lymphocytes and FBGCs.
3 | IMMUNOFLUORESCENT STAINING
3.1 | General
All stepswere performed at room temperature. Serial 2 μmsections of each
specimen were double-labeled with CD68 as the first marker in combina-
tion with various other markers (Table 1). CD68 was always stained with
fluorescein isothiocyanate (FITC), and the second marker with cyanine-5
(Cy5). All antibodies usedweremonoclonal and dilutedwith AntibodyDilu-
ent (with Background Reducing Components, Dako, Germany). Secondary
antibodies were applied with ImmPRESS™ HRP (Peroxidase) Polymer
DetectionKit (Vector, Laboratories, USA). Fluorochromeswere dilutedwith
1×Plus AmplificationDiluent (PerkinElmer, USA).
3.2 | Protocol
Tissue sections were deparaffinized with xylene, rehydrated through
graded alcohol and Milli-Q, before incubation in 3.5% formalin for
10 min. Sections were then placed in a cuvette filled with Milli-Q and
pH 6 citrate buffer (1:10) and treated with a Decloaking Chamber™
(Biocare Medical, USA) for 10 min at 110C. Afterward, sections were
washed with Milli-Q and TBST Tris (Buffered Saline with Tween
20, Dako) and cooled. Nonspecific binding was blocked by incubation
with Antibody Diluent for 10 min.
These steps were followed by incubation with the primary anti-
body of the first marker. After incubation, sections were rinsed in
TBST Tris and incubated with the secondary antibody for 20 min,
before applying FITC-staining with the Opal™ 520 Reagent Pack
(1:100, PerkinElmer) for 10 min. Sections were then washed with
TBST Tris and placed in a cuvette filled with AR6 Buffer (PerkinElmer)
TABLE 1 List of monoclonal
antibodies used.
Antibody Clone Dilution Incubation time Manufacturer
CD15 FUT4/815 1:600 Overnight Abcam
CD34 QBEND-10 1:2,500 Overnight Abcam
MMP8 EP1252Y 1:300 Overnight Abcam
CD16 c127 1:50 Overnight Acris
CD206 15–2 1:200 30 min Acris
TCR γ/δ B1 1:50 30 min BioLegend
CD163 5C6 FAT 1:800 Overnight BMA Biomedicals
CD3 F7.2.38 1:1,000 30 min Dako
CD4 4B12 1:500 30 min Dako
CD8 CD8/144B 1:500 30 min Dako
CD45 2B11 + PD7/26 1:2,000 30 min Dako
CD56 123C3 1:200 30 min Dako
CD68 KP1 1:6,000 30 min Dako
CD105 SN6h 1:25 Overnight Dako
Ki67 MIB-1 1:500 30 min Dako
FoxP3 PCH101 1:250 30 min eBioscience
AXL 7E10 1:800 30 min MyBioSource
CD86 BU63 1:200 Overnight Novus Biologicals
CD11b OTI12C10 1:2,000 30 min OriGene
Collagen-I 5D8-G9 1:125 Overnight ThermoFisher
Collagen-III FH-7A 1:200 30 min ThermoFisher
MMP2 CA-4001 or CA719E3C 1:300 Overnight ThermoFisher
Note: Monoclonal antibodies used in this study are sorted alphabetically by the manufacturer. Additional
information given are type of clone, dilution, and incubation time.
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and Milli-Q (1:10). The cuvette was microwave treated for 3 min at
385 W reaching a maximal temperature of 92C and 15 min at 120 W
reaching a maximal temperature of 90C, before being cooled with
cold water. Sections were removed and rinsed with Milli-Q, before
incubation with TBST Tris overnight.
The second marker was applied on the following day. After apply-
ing the primary and secondary antibodies of the second marker, sec-
tions were Cy5-stained with the TSA™-Plus Cyanine 5 System (1:50,
PerkinElmer). Sections were then rinsed in Milli-Q and counterstained
with TBST Tris diluted Spectral DAPI (1:12.5, PerkinElmer) for nuclei.
Finally, all tissue sections were mounted with VECTRASHIELD® Har-
dSet™ Antifade Mounting Medium (Vector) and coverslipped.
3.3 | Analysis of the fluorescence images/stainings
Fluorescence imaging was performed with an Axio Imager 2 microscope
(20×, Zeiss, Germany) and the TissueFAXS PLUS system (TissueGnostics,
Austria). Images were processed and quantitatively analyzed with
StrataQuest Analysis Software (v6, TissueGnostics). Optimized DAPI
images were used to detect and segment nuclei (Figure 2). Nuclei areas
were used to measure the mean staining intensities on FITC- and
Cy5-shades in selected 1 mm2 circular regions of interest (ROIs) that were
placed around mesh fibers, each including about 2,000–5,000 nuclei
(Figure 3). About 11 (median; range: 4–35) ROIs were analyzed in each
sample for all stainings to represent the FBG. The area of the entire sam-
ple without the area of the ROIs was considered mesh-scar tissue. We
recorded the total number of nuclei, as well as the percentages of FITC+
(CD68+), Cy5+ (second marker+), and the double-positive FITC+Cy5+
(CD68+ and second marker+) cells.
Additionally, controls without primary antibody and controls with
isotype antibodies were performed, the later with all dilutions and
incubation times (Figure 4). With a cut-off value of 100 for the mean
intensity in the nuclear area on average less than 2% of false-positive
cells were detected (Table 2).
3.4 | Statistical analysis
Calculations were done with MATLAB® 9.1 and Image Processing Tool-
box 9.5 (The MathWorks, USA). Statistical analysis was performed using
Statistical Package for Social Sciences software (SPSS® v23, IBM, USA).
Differences between groups and statistical p were assessed by the non-
parametric Mann–Whitney U test. The raw data required to reproduce
these findings are available on request from the authors.
4 | RESULTS
In different healthy human control tissues we always found some cells
stained positive for CD68 as well as for CD45+, CD8+, CD4+, or CD3+,
but cells that co-expressed CD68+ CD45+, CD68+ CD8+, CD68 + CD4+,
and CD68+ CD3+ were almost absent (<2% of all cells) (Figure 5;
F IGURE 2 Nuclei outlines on grayscale marker images and superimposed color image. (a) Grayscale image of CD68 stained with fluorescein
isothiocyanate (FITC). (b) Grayscale image of CD8 stained with. (c) Merge of DAPI colored in blue, CD68 colored in green, and CD8 colored in red.
Co-expressing CD68 + CD8+ cells are colored yellow. All images have been superimposed with the contours of the cell nuclei in solid green color
F IGURE 3 Regions of interest (ROI) selection. Tissue section of a
human mesh explant with selected circular ROI. Each ROI has an area
of 1 mm2, contains at least one mesh fiber, and 2,000–5,000 nuclei
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Table 3). In mesh-scar tissue, 19% of all cells were CD68+, and about
10% were positive for the lymphocyte markers CD3, CD4, or CD8.
However, co-expression of CD68 with CD45, CD3, CD4, or CD8 still
was rare (2.8–4.8% of all cells). In contrast, in the area of the FBG
around PP meshes, all these markers were seen abundantly, and co-
staining with CD68 was frequently found. Between 30 and 50% of the
CD68+ cells were positive for a second marker, and half of the cells
being positive for CD45+, CD8+, CD4+, and CD3+ were simultaneously
positive for CD68+ (Figure 6).
To test whether or not this dual-labeling was restricted to CD45,
CD8, CD4, and CD3 in PP meshes we expanded our analysis to a mesh
of another polymer and to further markers, which are considered to spec-
ify distinct cell types or reflect functional properties such as deposition of
collagen, including CD86 (M1), CD163 (scavenger receptor on macro-
phages, an innate immune sensor for bacteria), CD206 (M2), CD105 (part
of the TGF-β receptor complex, activated macrophages), CD16 (NK cell
marker I), CD56 (NK cell marker II), CD11b (Mac-1, dendritic cell marker),
TCR γ/δ, CD34 (stem cell), CD15 granulocytes, AXL, collagen-I and
collagen-III, MMP2 and MMP8. For all these markers, considerable num-
bers of single positive-labeled cells were observed in the FBG of meshes
made of both PP or PVDF, ranging from 2.2% CD86+ cells to 54.6% AXL+
cells around PP meshes, and from 1.2% CD86+ cells to 62.3% collagen-
III+ deposits around PVDF meshes, detected at PP mesh ROIs with mean
3,186 nuclei, PVDF mesh ROIs with mean 2,519 nuclei, respectively
(Figure 7; Table 4). While positively stained cells were mainly observed at
the mesh–tissue interface for most markers, this was not the case for
CD34, CD86, and MMP8, which usually were located outside the FBG.
FBGCs were positive for most markers, though showing strong heteroge-
neous staining patterns even within their multinucleated cell bodies.
Markers with high numbers of positive-labeled cells within the
inflammatory infiltrate usually showed higher cell densities closer to
the fibers, with no distinct zones that separate positive- and negative-
labeling. Most of these markers even displayed a local gradient with
continuously decreasing mean intensities with increasing distance
from the mesh fibers (Figure 8).
All markers tested showed substantial co-expression with CD68+
within the inflammatory infiltrate of the FBG, ranging from 5% for
CD68+CD86+ to 83% for CD68+AXL+ cells, mainly preferential close
to the mesh fibers (Figures 9 and 10a–d; Table 4).
To study whether or not the inflammatory infiltrate of the FBG
derives from proliferating cells, we looked for the expression of Ki67
at meshes, which at PP was found on average in 5.8% of the cells.
Furthermore, we identified 13.1% double-labeled CD68 + Ki67+ cells,
and 54.4% of Ki67+ cells co-expressed CD68, again mainly located in
the vicinity of the mesh fibers (Figure 11; Table 5).
The values for PVDF meshes were quite similar with 7.1% Ki67+,
and 13.3% CD68 + Ki67+, and 60.7% of Ki67+ cells co-expressed
CD68, respectively.
5 | DISCUSSION
Mesh-related complications are usually attributed to the foreign body
reaction characterized by chronic fibrotic inflammation at the mesh
boundary. Inflammation is governed by the types of immune cells on
F IGURE 4 Cumulative mean intensity distributions do not
indicate distinct subgroups. Cumulative mean intensity distributions
for all markers (e.g. CD68 labeled with fluorescein isothiocyanate
(FITC) and CD4 labeled with Cy5) at human mesh explants never
showed any s-shape or step, which would have reflected a distinct
cluster of positive-labeled cells with higher intensities. Instead, the
continuous smooth rise confirms the presence of a continuum and a
strong cellular heterogeneity, not indicating a distinct cut-off to
differentiate between positive- and negative-labeled cells. The curves
of controls are strongly left-shifted; the cut-off value of 100 detects
true positive cells with high intensities without including many false
positives as can be seen by the lowest percentage of 99.3% for
controls (positive predictive value >99%)
TABLE 2 Calculation of the positive
predictive value (PPV).
Marker
PPV
Cut-off 100 (%) Cut-off 80 (%) Cut-off 60 (%) Cut-off 40 (%)
CD68 (FITC) 99.8 99.7 98.8 92.4
CD3 (Cy5) 99.2 97.6 94.8 80.3
Note: PPV = (true positives)/(true positives + false positives) × 100%.
Note: True positives = Number of cells with a mean staining intensity above the cut-off value seen after
full staining with a specific monoclonal antibody.
Note: False positives = cells with a mean staining intensity above the cut-off value seen in controls with-
out primary antibody.
Note: Calculation of the PPV for different cut-off values for CD68 (FITC) and CD3 (Cy5). A cut-off value
>100 for the mean staining intensities yields PPVs >99%. Decreasing the cut-off value results in higher
rates of falsely positive detected cells.
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site. In the present study, we demonstrated that the inflammatory
infiltrate at explanted meshes from human patients displays extreme
heterogeneity and is quite dissimilar to that of a healing wound (scar
tissue). The simultaneous presence of these markers is indicative of a
spatial chronic inflammatory microenvironment primarily localized
around the foreign body and reflects the complex activation of these
cells possibly triggering their inherent inability for definitive healing.
When examined, the majority of antibody labeling was present at
the interface to clinical meshes, reflecting active recruitment. In situ
quantification of the staining intensity within the FBG revealed a
multi-marker pattern, indicating the high level of immune cell activa-
tion, as the majority of markers are known to up-regulate protein
expression after inflammatory signaling cascades (Heymann et al.,
2019). The local gradient with declining intensities in relation to the
distance of the foreign body underlines the impact of the local
conditions and questions the ability of in vitro experiments to reflect
this real-world scenario.
We identified that CD68+ cells co-express a variety of surface
markers, which usually are linked to other immune cells. Most of the
CD68+ cells are considered to be macrophages, and have been previ-
ously reported to show expression of CD45 (leucocytes), CD86 (pro-
inflammatory M1), CD206 (anti-inflammatory M2), CD16 (neutrophil/
natural killer cell marker), CD56 (natural killer cell marker I), CD11b
(part of the MAC-1 complement receptor), CD105 (part of the TGF
beta receptor complex, activated macrophages), or CD163 (scavenger
receptor on macrophages, an innate immune sensor for bacteria)
(Pilling, Fan, Huang, Kaul, & Gomer, 2009). However, we were sur-
prised that almost half of the CD68+ cells co-express lymphocytic
markers such as CD3, CD4 (helper T-cells), or CD8 (cytotoxic T-cells).
Gamma-delta T-cells can sometimes display macrophage morphology
(Wu et al., 2009); however, we identified only rare expression of T-
cell receptor γ/δ.
The enormous level of co-expression seen within the local inflam-
matory cells within the FBG can reflect the extended capabilities of
both macrophages and lymphocytes if such a strict distinction is still
useful. Perhaps these data just restore the historical idea of the pres-
ence of multipotent inflammatory or wound healing cells, considered
to be histiocytes by Aschoff (Yona & Gordon, 2015), macrophages by
Metschnikoff (Cavaillon, 2011), fibrocytes by Bucala (Bucala, Spiegel,
Chesney, Hogan, & Cerami, 1994), resting wandering cells by von
Recklinghausen (Guilliams et al., 2014), polyblasts by Maximow
(Jablonski & Meyer, 1938), or generally summarized as cells of the
macrophage system (Murray et al., 2014).
The explanation for this extreme heterogeneity could be the
radical adaptation of the immune system to eliminate an indigestible
foreign object. Such a reaction is commonly identified in parasite
infections, where the macrophages fuse and form giant cells
(Ruckerl & Allen, 2014). An identical phenomenon has been
observed at the interface to our meshes and has been reported even
between T cells and macrophages in HIV infection (Bracq et al.,
2017). However, multicell fusion cannot explain the heterogeneity
we observe at the mesh boundary, as the cells we identify are widely
mononuclear. An alternative mechanism could be emergency hema-
topoiesis, such as that occurring in cancer and infections, where
immature immune cells are recruited from the bone marrow and dis-
play stem-like properties (Boettcher & Manz, 2017). The level of
multipotency may allow expression of normally lineage-restricted
genes and proliferation at the site of the implant. Our data revealed
that the majority of Ki67+ cells (indicating proliferation potential)
were also positive for CD68, confirming these CD68 + Ki67+ cells
are not terminally differentiated and can proliferate in situ rather
than relying on newly recruited bone marrow monocytes, as has
been observed in monocyte-derived macrophages in mice (Davies,
Jenkins, Allen, & Taylor, 2013). This state-of-affairs may explain the
level of cross-lineage heterogeneity we observe, though a more
thorough examination by methods of lineage tracing as well as
extended multiplex stainings will help to unravel the underlying
mechanism (Baron & van Oudenaarden, 2019).
F IGURE 5 Comparison of healthy human liver tissue with a
foreign body granuloma of a human polypropylene (PP) mesh explant.
Scatterplots of the mean staining intensities from a healthy human
liver sample (left column, I–III), and of a human PP mesh explant (right
column, IV–V). The solid black lines mark the mean intensity cut-off
value 100 and the nucleus area cut-off value 5. Double positive-
labeled cells are in the upper right quadrants of scatter plots III and
VI. Percentages of cells in each quadrant are displayed in the outer
corners
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TABLE 3 Co-expression of cells in healthy human tissues and human mesh explants.
Staining
Spleen (645,513
to 742,442 nuclei)
Liver (34,079
to 43,125 nuclei)
Lymph node (199,598
to 267,760 nuclei)
Tonsil (409,571
to 784,518 nuclei)
Mesh-scar (8,876
to 507,584 nuclei)
FBG (2,814
to 5,003 nuclei)
CD68+ 1.2–3.1 2.6–3.3 0.5–2.8 0.1–0.4 18.6 (1.7) 28.7 (1.7)*
CD45+ 14.8 10.7 0.7 0.6 7.1 (1.2) 19.1 (1.8)*
CD8+ 8.1 5.3 2.4 17.8 10.9 (2.3) 18.6 (2.8)*
CD4+ 5.2 8.7 13.9 5.3 10.0 (1.7) 21.0 (3.2)*
CD3+ 19.0 5.8 10.8 10.6 10.4 (1.9) 20.2 (2.6)*
CD68 + CD45+ 0.3 0.9 0.0 0.0 2.9 (0.5) 10.2 (1.5)*
CD68 + CD8+ 0.0 0.1 0.0 0.0 3.5 (1.2) 8.6 (1.8)*
CD68 + CD4+ 0.3 0.9 0.9 0.1 4.8 (1.3) 13.1 (2.4)*
CD68 + CD3+ 0.1 0.1 0.0 0.0 4.4 (1.3) 9.8 (1.8)*
CD4 + CD8+ 1.6 1.9 0.1 1.6 3.5 (0.6) 7.8 (1.2)*
Note: Percentages of single and double “positive” cells with a mean intensity >100 in healthy human tissues (spleen, liver, lymph node, and tonsil), and in
15 human mesh explants (foreign body granuloma [FBG], and surrounding scar tissue [mesh-scar]). Data are presented as mean (SE). Statistical significance
between FBG and Scar was determined by Mann–Whitney U test. p-values <.05 were considered to be significant and marked by *.
F IGURE 6 Co-expression of cells
within the inflammatory infiltrate of
the foreign body granuloma. Double
immunofluorescence stainings of
human mesh explants for CD68
stained with fluorescein
isothiocyanate (FITC) (green) and
CD45, CD8, CD4, or CD3 stained
with Cy5 (red) on the left as well as
nuclei images on the right. Nuclei co-
expressing both markers are colored
in orange. Cells with a mean staining
intensity >100 are considered to be
“positive”
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F IGURE 7 Staining patterns in the
foreign body granuloma (FBG) around
polypropylene (PP) and polyvinylidene
fluoride (PVDF) meshes. Percentages of
positive-labeled cells in the FBG around
both materials (1,819 PP-ROIs and 1,305
PVDF-ROIs). Data are represented as
mean with whiskers (±SE). Statistical
significance between PP and PVDF
meshes was determined by Mann
Whitney U test. Markers with p-values
<.05 are marked with *
TABLE 4 Labeling of cells in the inflammatory infiltrate of the foreign body granuloma at seven human PP and five human PVDF mesh
explants.
PP meshes PVDF meshes
Marker+
Single positives
(marker+)
Double positives
(CD68 + marker+)
(CD68 + marker+)/
CD68+
Single positives
(marker+)
Double positives
(CD68 + marker+)
(CD68 + marker+)/
CD68+
CD68+ 25.7 (0.3) – – 30.4 (0.3) – –
CD3+ 19.2 (1.0) 8.3 (0.6) 29.9 (1.7) 11.2 (0.8)* 2.6 (0.3)* 10.0 (1.7)*
CD4+ 22.2 (1.2) 14.0 (0.9) 47.5 (1.9) 13.2 (1.0)* 7.8 (0.6)* 32.2 (2.5)*
CD8+ 17.1 (1.0) 8.1 (0.6) 36.0 (2.3) 17.2 (1.8) 6.7 (1.0) 32.6 (3.5)
CD11b+ 20.2 (1.5) 10.0 (0.9) 45.2 (2.6) 24.3 (1.2)* 16.3 (1.0)* 48.9 (2.3)
CD15+ 19.1 (1.3) 10.6 (0.9) 37.6 (2.2) 19.7 (1.4) 10.9 (0.9) 31.1 (2.4)*
CD16+ 33.7 (2.0) 12.8 (1.2) 52.0 (3.1) 23.0 (1.6)* 8.3 (0.7)* 33.5 (2.4)*
CD34+ 11.0 (0.7) 1.2 (0.1) 5.1 (0.8) 19.8 (1.0)* 2.7 (0.3)* 10.0 (1.2)*
CD45+ 22.7 (1.4) 8.1 (0.5) 41.3 (2.0) 34.6 (1.2)* 14.6 (1.0)* 54.1 (2.6)*
CD56+ 9.8 (1.1) 5.1 (0.6) 25.8 (3.0) 4.2 (0.6)* 3.1 (0.5)* 11.9 (1.7)*
CD86+ 2.2 (0.3) 0.7 (0.1) 5.0 (0.8) 1.2 (0.3)* 0.8 (0.2) 3.7 (0.8)*
CD105+ 43.9 (2.1) 13.5 (0.8) 64.2 (2.4) 26.6 (2.7)* 9.5 (1.0)* 46.0 (4.1)*
CD163+ 35.9 (1.6) 11.8 (0.6) 71.9 (1.7) 43.3 (2.4)* 25.0 (1.4)* 75.7 (2.7)*
CD206+ 14.5 (0.8) 9.7 (0.5) 63.5 (2.5) 27.1 (2.3)* 16.7 (1.1)* 60.4 (3.3)
AXL+ 54.6 (2.0) 17.9 (0.8) 83.1 (1.4) 57.2 (2.5) 21.8 (1.2)* 81.3 (2.5)
Collagen-I+ 25.2 (1.6) 10.7 (0.8) 60.6 (3.7) 33.2 (1.8)* 24.6 (1.2)* 64.8 (2.5)
Collagen-III+ 17.3 (1.5) 4.8 (0.5) 29.0 (2.2) 62.3 (2.0)* 25.9 (1.1)* 77.1 (2.1)*
FoxP3+ 24.7 (1.0) 9.9 (0.4) 42.1 (1.5) 19.4 (1.1)* 10.7 (0.7) 34.1 (2.0)*
Ki67+ 5.8 (0.3) 3.1 (0.2) 13.1 (0.7) 7.1 (0.4)* 7.1 (0.4)* 13.3 (0.7)
MMP2+ 34.7 (1.7) 22.9 (1.2) 57.4 (2.1) 27.1 (2.3)* 18.9 (1.7)* 46.3 (3.2)*
MMP8+ 2.9 (0.4) 1.2 (0.2) 3.5 (0.6) 2.8 (0.4) 0.9 (0.1) 2.1 (0.3)*
Note: Percentages of single-positive (marker+), and double-positive (CD68 + marker+) cells in reference to all cells as well as the quotient of
double-positive cells to CD68+ cells, meaning the percentage of double positives with reference to CD68+ cells. Data are presented as mean (SE). Statisti-
cal significance between PP and PVDF meshes was determined by Mann Whitney U Test. p-values <.05 are marked with *.
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In this study, we can demonstrate that the heterogeneity of
immune cells is not restricted to meshes made of PP, but is apparent
with meshes made of another polymer PVDF, as well, although with
differences mainly for the lymphocytic and collagen markers.
Considering the many problems recorded after the use of meshes
to reinforce tissues, it is the persistent local reaction, which underlies
the majority of these. The host tissue is not able to effectively seal
the foreign body in a stable wall of defending cells and extracellular
F IGURE 8 Decreasing mean staining intensities with increasing distance from the mesh fibers. (I) Regions of interest (ROI) from a human
mesh explant stained for anti-CD68 with fluorescein isothiocyanate (FITC). (II) Scatterplot with nucleus area on the x-axis and anti-CD68 mean
intensity on the y-axis. 30.1% of the cells within the ROI have a mean intensity >100 (red area). Cells with lower mean intensities are clustered in
steps of 20. Each cluster has an individual color assigned. (III) Cells colored according to their cluster within the ROI. Cells with high mean
intensities are displayed in red and dark orange, whereas cells with low mean intensities are displayed in yellow and white. (IV) Extraction of a
rectangular section with a mesh fiber in the center and surrounding inflammatory infiltrate. (V) The mean intensity profile of cells within 10 μm
segments shows a decreasing intensity gradient with increasing distance to the foreign body
F IGURE 9 Percentages of co-labeling
in CD68+ cells in the foreign body
granuloma (FBG) around polypropylene
(PP) and polyvinylidene fluoride (PVDF)
meshes. CD68 was always used as the
first marker and labeled with fluorescein
isothiocyanate (FITC), whereas secondary
markers were always labeled with Cy5.
The y-axis displays the percentages of
double positive-labeled cells in relation to
the CD68+ cells in the foreign body
granuloma. Data are represented as mean
with whiskers (±SE). Statistically
significant differences between PP and
PVDF meshes were determined by Mann
Whitney U test. Co-labeling with p-values
<.05 are marked with *
KLINGE ET AL. 9
F IGURE 10 Co-expressing cells within the inflammatory infiltrate of the foreign body granuloma. (a) Double immunofluorescence stainings
for CD68 stained with fluorescein isothiocyanate (FITC) (green) versus CD86, CD163, CD206, or CD11b stained with Cy5 (red) on the left as well
as nuclei images on the right. (b) Double immunofluorescence stainings with FITC (green) versus CD105, Collagen-I, Collagen-II, or TCR γ/δ
stained with Cy5 (red) on the left as well as nuclei images on the right. (c) Double immunofluorescence stainings with FITC (green) versus CD16,
CD56, CD15, or CD34 stained with Cy5 (red) on the left as well as nuclei images on the right. (d) Double immunofluorescence stainings with FITC
(green) versus AXL, MMP8, MMP2, or FoxP3 stained with Cy5 (red) on the left as well as nuclei images on the right. Nuclei co-expressing both
markers are colored in orange. Cells with a mean staining intensity >100 are considered to be “positive”
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matrix. Instead, an inflammatory environment is maintained with
intense cell turnover, tissue remodeling, and cell migration, which
leads to enhanced fibrosis, stiffness, erosion of adjacent organs,
nerve entrapment, and pain. At least in some patients, this chronic
process with the permanent activation of inflammatory immune cells
can open the door for a systemic inflammatory response syndrome
with subsequent complaints or even autoimmune diseases (Cohen
Tervaert, 2018).
As a never healing process, the risks will accumulate over the
years, questioning mesh utilization for young patients. Future
attempts to improve the biocompatibility of meshes should focus on
the reduction of the heterogeneous inflammatory infiltrate and the
promotion of normal wound healing mechanisms.
Several limitations have to be considered. Our collection of
explanted human mesh samples represents a selection of apparent
mesh failures, often with insufficient knowledge about the various
materials used, and with different intervals after implantation into
non-healthy tissues. However, the current problem of meshes is the
relation to some complications, and we have to understand why this
happens. Many patients obviously can tolerate meshes without any
problems, and it can be speculated that these patients may have a dis-
tinct immunological response. But at least in patients, who require a
revision operation, the local inflammatory cells of the FBG revealed a
complex pattern of activation. Future studies have to show, whether
the downregulation of this inflammation is able to reduce the side
effects and complications.
The indication for mesh explantation may affect the tissue reac-
tion seen, whether the reason is recurrence, pain, or infection. In par-
ticularly any bacterial infection, either low or high grade is supposed
to change the local tissue response. However, considering our experi-
ence with histopathological analysis of explanted meshes, we consid-
ered the meshes used in this study to be representative. Any larger
sample size will hardly change the principal finding of substantial co-
expression in CD68+ cells substantially. Due to the limited clinical
data provided any meaningful correlation between outcome and the
tissue response requires huge cohorts with a prospective data assess-
ment. Additionally, to the many confounders given by the complex
staining protocol, it is the location and size of the ROI of course that
F IGURE 11 Proliferation of cells within the inflammatory
infiltrate of the foreign body granuloma. (I) Nuclei stained with DAPI
colored in white, (II) nuclei and proliferating Ki67+ cells stained with
Cy5 colored in red, (III) nuclei and CD68+ cells stained with
fluorescein isothiocyanate (FITC) colored in green, and (IV) overlay of
the original shades (DAPI in blue, CD68 in green, and Ki67 in red).
Cells were considered to be “positively” stained if their mean staining
intensity was greater than 100
TABLE 5 Evaluation of the proliferation within the inflammatory infiltrate of the foreign body granuloma.
Staining
PP mesh (by mesh-sample) (n = 7) PVDF mesh (by mesh-sample) (n = 5)
Mean Min Max Mean Min Max
CD68+ 23.1 15.3 23.1 31.4 25.1 35.4
Ki67+ 5.5 9.8 2.3 6.8 4.4 10.5
CD68 + Ki67+ 3.1 4.9 1.3 4.0 2.2 6.3
CD68 + Ki67+/CD68+ 12.9 8.5 20.9 12.4 6.6 17.8
CD68 + Ki67+/Ki67+ 56.6 43.4 70.7 57.9 35.9 69.8
Note: Analysis of co-expression for CD68 + Ki67+, and co-expression in relation to either CD68+ or Ki67+ within the foreign body granuloma of human
mesh explants. Data are presented in mean percentages of seven PP meshes and five PVDF meshes (11–18 regions of interest each). Positive cells have a
mean staining intensity >100.
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can affect the results. Extended inflammation with an ROI limited to
the infiltrate of the FBG will lead to increased cell counts, whereas
large ROIs that include wide areas of polymeric fibers, adjacent fat tis-
sue, or excessive collagen deposits will show reduced numbers of
nuclei. Correspondingly, the percentage of co-expressing cells may be
affected. Our choice of an ROI of 1 mm2, which usually includes about
2,000–5,000 cells of the inflammatory infiltrate, covers most of the
inflammatory infiltrate around a mesh fiber. Even if parts of the ROI
include adjacent noninflammatory tissues, it is both the number of
CD68+ cells and the number of cells being positively stained with a
second marker, which are reduced. Subsequently, the percentage of
co-expressing CD68+ cells remains widely constant, which therefore
can serve as the robust but specific property of the mesh. The analysis
of the staining intensity only in the area of the nuclei cannot exclude
that despite thin sections of about 2 μm the positive staining might be
based on some overlapping cytoplasm membrane, but it offers the
option to define positively stained cells in an objective and reliable
way. To assure ourselves that our method identified true co-expres-
sion, we applied a cut-off fluorescence value of 100. This approach
ensured a high PPV, which provides us with the most confidence for
true positive selection. However, in some cases, the use of a lower
cut-off value could have been argued, which would lead to higher per-
centages of double and single “positive” cells, at the loss of objectivity.
It should be noted that lowering this cut-off only supports the conclu-
sions of this study.
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